Multiple Sclerosis (MS) is an autoimmune disease that causes the body’s immune system to attack his central nervous system. The most common form of MS is relapsing-remitting MS, which is characterized by random spouts of symptoms. There are medications designed to manage the condition, but they are not always effective.
A Better Solution
Researchers are now confident that they have come up with a more effective way of treating relapsing-remitting MS. It involves stem cell transplants and high doses of immunosuppressive therapy. The patient’s blood-forming stem cells are extracted and preserved, after which the patient undergoes high-doses of immunosuppressive therapy. The extracted stem cells are then re-introduced into the body to rebuild the depleted immune system.
The researchers found out that this single procedure is capable of sustaining remission of the condition for much longer than current medications do. And, although the risks have not been fully identified yet, there is optimism that it will be less risky than current medications as the researchers refine their findings.
This new form of treating relapsing-remitting MS has been under study for five years now in a trial dubbed HALT-MS. It involved 24 volunteers aged between 26 and 52 who experienced relapses in spite of taking clinical medications. Most of the participants have stayed in remission since the medication was administered at the start of the trial. Additionally, several participants have experienced improvements such as recovery of some disabilities.
About Dr. Shiva Vasishta
Dr. Shiva Gopal Vasishta is a practicing neurologist and psychiatrist in Voorhees, NJ. He also practices at the Eastern Neurodiagnostic Associates. He attended the Government Medical College in 1979 and harnessed his skills while in residency at the Boston City Hospital.
Dr. Shiva Vasishta is also an affiliate of Kennedy Health System Cherry Hill Campus. His hospital accepts a wide range of insurance plans.